Formulation and evaluation of press coated tablets for pulsatile drug delivery using hydrophilic and hydrophobic polymers

Chemical and Pharmaceutical Bulletin

Volumn 57, Issue 11, 2009, Pages 1213-1217

  Rane, Ashish Babulal ^a   Gattani, Surendra Ganeshlal ^a   Kadam, Vinayak Dinkar ^a   Tekade, Avinash Ramrao ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Ketoprofen; Lag time; Press coated tablet; Time controlled disintegration

Indexed keywords

ALGINIC ACID; ETHYL CELLULOSE; KETOPROFEN; POLYMER;

ARTICLE; CALORIMETER; DIFFERENTIAL SCANNING CALORIMETRY; DRUG COATING; DRUG FORMULATION; DRUG SCREENING; HYDROPHILICITY; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MATERIAL COATING; PARTICLE SIZE; PULSATILE DRUG RELEASE; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TABLET SURFACE; VISCOSITY; WEIGHT;

ALGINATES; CALORIMETRY, DIFFERENTIAL SCANNING; CELLULOSE; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG STABILITY; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROPHOBICITY; KETOPROFEN; MOLECULAR WEIGHT; PARTICLE SIZE; POWDERS; SOYBEANS; SURFACE PROPERTIES; TABLETS; TIME FACTORS; VISCOSITY;

EID: 71049165243     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.57.1213     Document Type: Article

References (22)

1. Smolensky M. H., Reinberg A. E., Martin R. J., Haus E., Chronobiol. Int., 16, 539-563 (1999).
2. Berner B., John V., Clin. Pharmacokinet., 26, 121-134 (1994).
3. Smith D. H., Neutel J. M., Weber M. A., Am. J. Hypertens., 14, 14-19 (2001).
4. Takeuchi H., Yasuji T., Yamamoto H., Kawashima Y., Pharm. Res., 17, 94-99 (2000).
5. Gonzalez-Rodriguez M. L., Maestrelli F., Mura P., Rabasco A. M., Eur. J. Pharm. Sci., 20, 125-131 (2003).
6. Ozekia Y., Ando M., Watanabe Y., Danjo K., J. Controlled Release, 95, 51-60 (2004).
7. Asford M., Fell J. T., Attwood D., Woodhead P. J., Int. J. Pharm., 91, 241-245 (1993b).
8. Friend D. R., Adv. Drug Deliv. Rev., 7, 149-199 (1991).
9. Kinget R., Kalala W., Vervoort L., Van den M. G., J. Drug Target., 6, 129-149 (1998).
10. Rubinstein A., Crit. Rev. Ther. Drug Carrier Syst., 12, 101-149 (1995).
11. Leopold C., Eikeler D., Drug Dev. Ind. Pharm., 26, 1239-1246 (2000).
12. Fallingborg J., Christensen L. A., Ingeman-Nielsen M., Jacobsen B. A., Abildgaard K., Rasmussen H. H., Aliment. Pharmacol. Ther., 3, 605-613 (1989).
13. Lin S. Y., Lin K. H., J. Pharm. Sci. Technol. Jpn., 55, 254-260 (1995).
14. Kalidindi S. R., Shangraw R. F., Drug Dev. Ind. Pharm., 8, 15-235 (1982).
15. Giunchedi P., Gavini E., Domenico M., Moretti L., Pirisino G., AAPS PharmSciTech, 1, 19-23 (2000).
16. Ozeki Y., Watanabe Y., Inoue S., Danjo K., Int. J. Pharm., 267, 69-78 (2003).
17. Qi M., Wang P., Wu D., Drug Dev. Ind. Pharm., 29, 661-667 (2003).
18. Guo H. X., Shi Y. P., Int. J. Pharm. (2009).
19. Ahmed A., Souad S., Afr. J. Pharm. Pharmacol., 2, 153-156 (2008).
20. Qureshi J., Amir M,, Ahuja A., Baboota S., Ali J., Indian J. Pharm. Sci., 70, 351-356 (2008).
21. Tekade A., Gattani S., Pharm. Dev. Technol. (2009).
22. Sruamsiri S., Silman P., Mj. Int. J. Sci. Tech., 2, 568-576 (2008).